National Institute of Mental Health – The National Institute of Mental Health (NIMH) is the lead federal agency for research on mental disorders and under the umbrella of the National Institutes of Health (NIH).
National Institute of Aging – The National Institute of Aging (NIA), is one of the 27 Institutes and Centers of National Institutes of Health (NIH), leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life. NIA is the primary Federal agency supporting and conducting Alzheimer’s disease research.
National Institute of Drug Abuse – The mission of National Institute of Drug Abuse (NIDA) is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health.
Knight Alzheimer Disease Research Center – The Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC) is one of 32 centers funded by the National Institute on Aging with the collective aim of facilitating advanced research on clinical, genetic, neuropathological, neuroanatomical, biomedical, psychosocial, and neuropsychological aspects of Alzheimer disease and related brain disorders.
Institute of Clinical and Translational Sciences – The Institute of Clinical and TranslationalSciences (ICTS) funding helps investigators with innovative ideas overcome initial data and feasibility hurdles to facilitate the exploration of new concepts, the development of new technologies, or the advancement of creative new solutions to intractable clinical, translational, or population health problems. They support research across the translational science spectrum by integrating and coordinating a variety of funding programs with local, regional, and national partners through a model of reciprocal review and joint funding.
Infectious Diseases Society of America Foundation – The Infectious Diseases Society of America (IDSA) Foundation has taken major steps to impact the field of infectious diseases including HIV by empowering the next generation of leaders. Their commitment to increasing the number of doctors practicing in the field of infectious diseases and HIV ensures there will be a strong pipeline of highly qualified ID and HIV specialists.
Rodger and Paula Riney Fund – The Riney’s have first-hand experience in dealing with the ravages of neurodegenerative diseases such as Alzheimer’s and Parkinson’s: Both had a parent who suffered from dementia, which occurs in all Alzheimer’s patients and 80 percent of Parkinson’s patients. “The cost of Alzheimer’s and Parkinson’s on families and society is just devastating,” said Rodger Riney. “We felt we wanted to do something substantive to help solve these problems. We were very impressed with the work at Washington University to find effective treatments and improve early diagnosis for these diseases, and we wanted to make a significant investment that would accelerate this important research.”
Brennan Fund – Daniel J. Brennan, MD, left a bequest to the School of Medicine to create the Daniel J. Brennan, MD, Research Fund to support Alzheimer’s disease research. In 2017, a portion of his gift was used to establish the Daniel J. Brennan, MD, Professorship in Neurology in the Charles F. and Joanne Knight Alzheimer’s Disease Research Center. Beau M. Ances, MD, PhD, was named the inaugural Daniel J. Brennan, MD, Professor of Neurology at Washington University School of Medicine in St. Louis in 2018.
Dana Foundation – The Dana Foundation is a private philanthropic organization dedicated to advancing understanding about the brain.
amFAR – amfAR’s top research priority is the pursuit of a cure for HIV/AIDS. amfAR is also a leading advocate of continued robust U.S. support for the global HIV response.
UARP – The University AIDS Research Program (UARP) was established in 1983 to provide support of meritorious research projects related to AIDS at various nonprofit research institutions.